CMV Disease In Stem Cell Transplantation: Prevention And Drug Resistance

Main Category: Infectious Diseases / Bacteria / Viruses
Also Included In: Stem Cell Research
Article Date: 15 Aug 2008 - 2:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in recipients of hematopoietic stem cell transplantation. The clinical manifestations of CMV disease are serious and range from gastrointestinal disease to life-threatening pneumonia, myelosuppression, retinitis, and encephalitis.

In order to prevent CMV infection and reduce CMV drug resistance, it is vital that healthcare professionals involved in the treatment of hematopoietic stem cell transplant recipients understand current strategies for management of CMV, including prophylaxis and treatment. To address the need for education on CMV management, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) have jointly sponsored a free continuing education monograph for physicians and clinical pharmacists.

Faculty authors for this activity include infectious disease experts Michael J. Boeckh, MD, from the Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine in Seattle, Washington and Sunwen Chou, MD, from the Oregon Health & Science University in Portland, Oregon.

This continuing education activity is jointly sponsored by RMEI and Postgraduate Institute for Medicine and is supported by an educational grant from ViroPharma, Incorporated.

"Robert Michael Educational Institute LLC recognizes that continuing medical education plays a crucial role in the provision of quality health care and is dedicated to offering professionals meaningful opportunities for lifelong learning," says President and CEO, Robert M. Colleluori.

RMEI is a full-service medical education company dedicated to providing comprehensive medical education to healthcare providers. RMEI works closely with medical experts to design activities that improve diagnosis and treatment. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For additional educational offerings, please visit http://www.RMEI.com.

Robert Michael Educational Institute LLC
http://www.RMEI.com